Abstract:Vascular calcification (VC) is a common pathological manifestation of atherosclerosis, hypertension, diabetes vascular disease, vascular injury, chronic kidney disease and aging, which is mainly manifested as increased stiffness of the vascular wall. Oxidative stress and autophagy dysfunction are key factors in the pathogenesis of vascular calcification, but the specific mechanisms and the therapeutic strategy of vascular calcification have not been clarified. In the present study, Sirtuin 1 (SIRT1) was screened as the therapeutic targets for vascular calcification by the bioinformatics. SIRT1 is a nicotinamide adenine dinucleotide, which plays an important role in inhibiting oxidative stress and promoting autophagy. Luteolin (LUT), a kind of natural tetrahydroxyl flavonoid, exists in many plants and has many pharmacological effects such as anti-oxidation and anti-apoptosis. We have reported that luteolin has certain anti-osteoporosis effects in the previous study, and it is accepted that the development of vascular calcification is similar to bone formation, indicating that luteolin may also resist vascular calcification. And luteolin is known to activate SIRT1 to some extent. Moreover, the molecular docking analysis predicted that SIRT1 could bind directly to luteolin. Therefore, the purpose of this study was to investigate the potential role of luteolin in inhibiting oxidative stress and promoting autophagy during vascular calcification via modulating SIRT1 expression. The results showed that luteolin significantly improved vascular calcification induced by a high-fat diet (HFD) and vitamin D3 in rats in vivo. In addition, luteolin significantly repressed the formation of mineralized nodules and ALP activity in H2O2-treated A7r5 cells. Luteolin reduced the level of MDA, LDH and ROS generation, inhibited the protein expression of cleaved caspase-3, cleaved caspase-9, β-catenin and BMP-2 in the aortic tissue of the rat and rat smooth muscle cells (A7r5) treated with hydrogen peroxide. At the same time, luteolin could promote the expression of autophagy related proteins. Moreover, luteolin also produced effects to increase the protein expression levels of SIRT1 more than 2 times both in vivo and in vitro. In terms of mechanism, luteolin attenuated vascular calcification by inhibiting oxidative stress and improving autophagy level, via modulating SIRT1 / CXCR4 signaling pathway. In conclusion, this experiment for the first time revealed that LUT protected against VC via modulating SIRT1 / CXCR4 signaling pathway to promote autophagy and inhibit vascular calcification and may be developed as a new therapeutic agent for vascular calcification and atherosclerosis.

Triptolide Attenuates Vascular Calcification by Upregulating Expression of miRNA-204

Triptolide Attenuates Transplant Vasculopathy Through Multiple Pathways

Mitochondrial-Derived Peptide MOTS-c Attenuates Vascular Calcification and Secondary Myocardial Remodeling Via Adenosine Monophosphate-Activated Protein Kinase Signaling Pathway.

miR-146-5p restrains calcification of vascular smooth muscle cells by suppressing TRAF6

Moscatilin inhibits vascular calcification by activating IL13RA2-dependent inhibition of STAT3 and attenuating the WNT3/β-catenin signalling pathway

Curcumin attenuates vascular calcification via the exosomal miR-92b-3p/KLF4 axis

MicroRNA-204 Regulates Vascular Smooth Muscle Cell Calcification in Vitro and in Vivo.

Overexpression of miR-204-5p Alleviates Osteogenic Differentiation and Calcification of Human Aortic Vascular Smooth Muscle Cells by Targeting Calcium/Calmodulin-dependent Protein Kinase 1

The Protective Effect of GLP-1 Analogue in Arterial Calcification Through Attenuating Osteoblastic Differentiation of Human VSMCs

D-box-binding protein alleviates vascular calcification in rats with chronic kidney disease by activating microRNA-195-5p and downregulating cyclin D1

Molecular mechanism of triptolide in myocardial fibrosis through the Wnt/β-catenin signaling pathway

Tetramethylpyrazine Inhibits Agiontensin II-induced Nuclear Factor-Kappab Activation and Bone Morphogenetic Protein-2 Downregulation in Rat Vascular Smooth Muscle Cells.

[Tanshinone IIa attenuates vascular calcification through inhibition of NF-κB and β-catenin signaling pathways]

CTRP13 Attenuates Vascular Calcification by Regulating Runx2

Thyroid Hormone Attenuates Vascular Calcification Induced by Vitamin D3 Plus Nicotine in Rats

Piperlongumine Attenuates High Calcium/Phosphate-Induced Arterial Calcification by Preserving P53/PTEN Signaling

Identification of miR136, miR155, and miR183 in vascular calcification in human peripheral arteries

Resveratrol Protects Against Triptolide-Induced Cardiotoxicity Through SIRT3 Signaling Pathway in Vivo and in Vitro.

Notoginsenoside R1-Protocatechuic Aldehyde Reduces Vascular Inflammation and Calcification Through Increasing the Release of Nitric Oxide to Inhibit TGFβR1-YAP/TAZ Pathway in Vascular Smooth Muscle Cells

Luteolin Protects against Vascular Calcification by Modulating SIRT1/CXCR4 Signaling Pathway and Promoting Autophagy

Curcumin Attenuates Osteogenic Differentiation and Calcification of Rat Vascular Smooth Muscle Cells